Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination. - Wikidata - awgldk - TriplyDB

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

http://www.wikidata.org/entity/Q37198835

about

Evasion of host immune defenses by human papillomavirus Immunoprevention of human papillomavirus-associated malignancies Anti-tumor effects of genetic vaccines against HPV major oncogenes.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.Nucleic acid vaccination strategies against infectious diseases.Current state in the development of candidate therapeutic HPV vaccines Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro.

P2860

Q28076194-3430076A-2E6C-416F-8472-418C44B2D8F2 Q35044376-AF6C0A32-D922-4E6C-B780-C7E558388172 Q35887186-B8BF1C5D-32A6-4595-993D-8576C4FCF464 Q37579334-29B4C605-332A-4611-9AE2-721C42F1F763 Q38537768-72E7E873-5FFD-4239-B9C4-176B2EED9491 Q38586079-EAA05D0B-8EE8-4F18-B7AE-71B8249F065A Q38743922-83291ED0-3708-4A1D-A965-0BB03B32548D Q38924569-1B2445C8-65B1-41EF-BD81-473EED0FA1F2 Q50115667-EDAB57EB-5CF6-4811-8DD0-6E5F890F0C3E Q51286736-C804A968-CF7E-4B56-BC36-2939AB0ABE28

P2860

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

http://www.wikidata.org/entity/Q37198835

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@en

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@nl

type

label

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@en

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@nl

prefLabel

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@en

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@nl

P1433

Q37198835-D744211F-9485-423B-AFDC-B5E273C2E441

P1476

Q37198835-F89F7E7E-7D58-4384-A796-B8E32CC4CF45

P2093

Q37198835-019B2FE1-9B7A-4084-ACB1-8D716E63E412

Q37198835-06AC76F3-F2AF-4B78-A126-651197392850

Q37198835-0E59E562-2D7D-423E-A30F-7ED417E808F4

Q37198835-442EE1D3-DC20-47D4-8BCE-EEAB5DE12A79

Q37198835-61555DB8-F36F-4E24-B295-411942DB5D5B

Q37198835-6CB532BD-9C94-464B-BA5A-BDD7A521123B

Q37198835-C399894A-AC07-477F-9102-AFDC27AD5B8C

Q37198835-CAECFC99-7BA3-40AE-BC04-1098D06E6F92

Q37198835-CB554E3A-1B6B-436C-87BE-D1693D7796B3

Q37198835-EE0E3244-C6A5-4563-8A56-0572A84AF7BA

P2860

Q37198835-09EA892C-2EED-4BCE-8A46-453712D87323

Q37198835-19F32628-58C4-4609-B28C-2C88DAE1DE65

Q37198835-20392CB0-830E-4A0E-8F3D-59382465DCB0

Q37198835-2222F2E9-A751-48CA-8649-9141B059E3E7

Q37198835-270B4FE4-17C2-4CEA-806B-DD46301BD946

Q37198835-27C59D62-AF66-4531-BB27-4CB44CB046B5

Q37198835-296E1A89-D8B6-466B-8B68-16141C254CF1

Q37198835-29B13048-3F4F-459F-AD4F-10FD874D6D4E

Q37198835-29C8CED6-DB1B-4843-A486-666A9B54B898

Q37198835-3ACD4184-9856-437D-8074-50EE8A5D2747

P2888

Q37198835-B768C38D-75DA-4667-ACAA-76301150865E

P304

Q37198835-25FB4E82-521A-43DF-AC72-7BECDDAD03CF

P31

Q37198835-6582DA7A-9A95-4A89-8350-17B60BE22BC1

P356

Q37198835-43F15FB7-49CF-41D6-BD84-448E0F3D9621

P433

Q37198835-909FC5AD-46BD-4853-A823-414E365DDE02

P478

Q37198835-FA9DA60E-DF23-4903-831D-97105C70C5CA

P577

Q37198835-8A2B447E-AA8E-4C73-8F11-955687B035AA

P5875

Q37198835-1CA68210-4BC4-4DBD-A2E5-46B0D2ED2B27

P698

Q37198835-00426D03-1309-4B32-B851-F7AA1569F842

P932

Q37198835-E35A31F8-EF81-49AD-BEA8-747D59489AF3

P356

S00109-013-1054-9

P1433

Journal of Molecular Medicine

P1476

Histone deacetylase inhibitor ...... erapeutic HPV DNA vaccination.

@en

P2093

Chenguang Wang

http://www.w3.org/2001/XMLSchema#string

Chien-Fu Hung

http://www.w3.org/2001/XMLSchema#string

Ching-Shih Chen

http://www.w3.org/2001/XMLSchema#string

Ellen Axenfeld

http://www.w3.org/2001/XMLSchema#string

Jayne Knoff

http://www.w3.org/2001/XMLSchema#string

Ronald D Alvarez

http://www.w3.org/2001/XMLSchema#string

Ruey-Shyang Soong

http://www.w3.org/2001/XMLSchema#string

Sung Yong Lee

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Tae Heung Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer

The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo

Anticancer activities of histone deacetylase inhibitors

Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

Calreticulin: one protein, one gene, many functions.

Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.

Histone deacetylases: unique players in shaping the epigenetic histone code.

Histone deacetylase inhibitors: discovery and development as anticancer agents.

P2888

s00109-013-1054-9

P304

1221-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-013-1054-9

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236958089

http://www.w3.org/2001/XMLSchema#string

P698

23715898

http://www.w3.org/2001/XMLSchema#string

P932

3783646

http://www.w3.org/2001/XMLSchema#string